ATE301672T1 - Methode zur reinigung eines erythrpoietinbindenden proteins - Google Patents

Methode zur reinigung eines erythrpoietinbindenden proteins

Info

Publication number
ATE301672T1
ATE301672T1 AT97906426T AT97906426T ATE301672T1 AT E301672 T1 ATE301672 T1 AT E301672T1 AT 97906426 T AT97906426 T AT 97906426T AT 97906426 T AT97906426 T AT 97906426T AT E301672 T1 ATE301672 T1 AT E301672T1
Authority
AT
Austria
Prior art keywords
ebp
protein
epo
binding
drug design
Prior art date
Application number
AT97906426T
Other languages
English (en)
Inventor
Steven A Middleton
Dana Johnson
Frank J Mcmahon
Linda S Mulkahy
Linda K Jolliffe
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE301672T1 publication Critical patent/ATE301672T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97906426T 1996-01-23 1997-01-22 Methode zur reinigung eines erythrpoietinbindenden proteins ATE301672T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1046996P 1996-01-23 1996-01-23
US2212996P 1996-07-18 1996-07-18
PCT/US1997/000932 WO1997027219A1 (en) 1996-01-23 1997-01-22 Methods for purification and use of erythropoietin binding protein

Publications (1)

Publication Number Publication Date
ATE301672T1 true ATE301672T1 (de) 2005-08-15

Family

ID=26681222

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97906426T ATE301672T1 (de) 1996-01-23 1997-01-22 Methode zur reinigung eines erythrpoietinbindenden proteins

Country Status (7)

Country Link
EP (1) EP0909274B1 (de)
JP (1) JP4060361B2 (de)
AT (1) ATE301672T1 (de)
AU (1) AU729540B2 (de)
DE (1) DE69733950T2 (de)
ES (1) ES2246506T3 (de)
WO (1) WO1997027219A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5203199A (en) * 1998-05-26 1999-12-13 Procter & Gamble Company, The Chimeric molecules comprising an extracellular ligand binding domain of a receptor and an ige fc or constant region, and their use in an assay system
WO2010151688A2 (en) 2009-06-25 2010-12-29 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
JP6366303B2 (ja) * 2014-03-06 2018-08-01 東ソー株式会社 エリスロポエチン結合性タンパク質

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008822A1 (en) * 1989-02-03 1990-08-09 Genetics Institute, Inc. Erythropoietin receptor

Also Published As

Publication number Publication date
DE69733950T2 (de) 2006-07-06
AU2112297A (en) 1997-08-20
AU729540B2 (en) 2001-02-01
DE69733950D1 (de) 2005-09-15
EP0909274A4 (de) 2000-01-19
JP4060361B2 (ja) 2008-03-12
WO1997027219A1 (en) 1997-07-31
ES2246506T3 (es) 2006-02-16
JP2001507670A (ja) 2001-06-12
EP0909274A1 (de) 1999-04-21
EP0909274B1 (de) 2005-08-10

Similar Documents

Publication Publication Date Title
Dedman et al. Biological cross-reactivity of rat testis phosphodiesterase activator protein and rabbit skeletal muscle troponin-C.
Baines et al. Synapsin I is a spectrin-binding protein immunologically related to erythrocyte protein 4.1
ATE522610T1 (de) Menschliche, metabotrope glutamatrezeptor- subtypen (hmr6) und verwandte dns-verbindungen
ATE421977T1 (de) Reinigung von peptiden unter verwendung von metall-ion-affinitätschromatographie
KR890012000A (ko) 인간 b세포 자극인자-2에 대한 수용체 단백질
AU702557C (en) Novel protein and methods for producing the proteins
ATE119198T1 (de) Verfahren zur herstellung von proteinen mittels rekombinanter dna.
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
PT686161E (pt) Novas sub-unidades humanas de alfa integrina 2
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
CA2288373A1 (en) Human cerberus protein
ATE301672T1 (de) Methode zur reinigung eines erythrpoietinbindenden proteins
Smit et al. Caulobacter crescentus pilin. Purification, chemical characterization, and NH2-terminal amino acid sequence of a structural protein regulated during development.
ATE221082T1 (de) Das polypeptid eines membran-proteins mit der funktion zur unterstützung des wachstums von prä- b zellen und sein gen
DK326289D0 (da) Fremgangsmaade til fremstilling af et protein ud fra gaersvampe under anvendelse af et inducerbart system, samt vektorer og transformerede stammer til brug ved fremgangsmaaden
CA2243577A1 (en) Methods for purification and use of erythropoietin binding protein
DE69130530D1 (de) Methode zur bildung eines aminosäurehydantoinderivats unter verwendung eines n-substituierten ketenimins als aktivator
Adam et al. Cytoplasmic factors in NLS-mediated targeting to the nuclear pore complex
Flanagan et al. Comparative studies on the characteristic properties of two forms of brain actin separable by isoelectric focussing
DE59914878D1 (de) Neuer spannungsabhängiger kaliumkanal und seine verwendung zur entwicklung von therapeutika
US5434245A (en) Polypeptides and method for preparing the same
Khamidov et al. Immunoaffinity fractionation of neutralizing polyclonal antibodies to nerve growth factors
WO2002012334A3 (en) Snake venom polypeptide zsnk1
MX9708107A (es) Subunidad alfa de integrina beta 2 humana.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties